-
EP3381472
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3381472
| EP3381472 - DRUG FOR TREATING OR PREVENTING DISORDER CAUSED BY TGF- SIGNALS, AND APPLICATION THEREOF [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 18.12.2020 Database last updated on 15.06.2024 | |
| Former | Request for examination was made Status updated on 31.08.2018 | ||
| Former | The international publication has been made Status updated on 05.07.2017 | Most recent event Tooltip | 15.11.2023 | New entry: Renewal fee paid | Applicant(s) | For all designated states The Doshisha 601, Gembu-cho Karasuma-higashi-iru Imadegawa-dori Kamigyo-ku, Kyoto-shi Kyoto 602-8580 / JP | [2018/40] | Inventor(s) | 01 /
KOIZUMI, Noriko c/o DOSHISHA UNIVERSITY 1-3 Tatara Miyakodani Kyotanabe-shi Kyoto 610-0394 / JP | 02 /
OKUMURA, Naoki c/o DOSHISHA UNIVERSITY 1-3 Tatara Miyakodani Kyotanabe-shi Kyoto 610-0394 / JP | [2018/40] | Representative(s) | Engelhard, Markus Boehmert & Boehmert Anwaltspartnerschaft mbB Pettenkoferstrasse 22 80336 München / DE | [2018/40] | Application number, filing date | 16877997.3 | 22.12.2016 | [2018/40] | WO2016JP05215 | Priority number, date | JP20150251786 | 24.12.2015 Original published format: JP 2015251786 | [2018/40] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017110093 | Date: | 29.06.2017 | Language: | JA | [2017/26] | Type: | A1 Application with search report | No.: | EP3381472 | Date: | 03.10.2018 | Language: | EN | [2018/40] | Search report(s) | International search report - published on: | JP | 29.06.2017 | (Supplementary) European search report - dispatched on: | EP | 03.07.2019 | Classification | IPC: | A61K31/4418, A61K31/4439, A61K31/4412, A61K45/00, A61P27/02, A61P43/00 | [2019/31] | CPC: |
A61K31/4439 (EP,US);
A61K31/17 (US);
A61K31/4412 (EP,US);
A61K31/4418 (EP,US);
A61K31/573 (EP,US);
A61K45/06 (EP,US);
|
| Former IPC [2018/40] | A61K45/00, A61K31/4412, A61K31/4418, A61K31/4439, A61P27/02, A61P43/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/40] | Title | German: | ARZNEIMITTEL ZUR BEHANDLUNG ODER VORBEUGUNG VON DURCH TGF-SIGNALE VERURSACHTEN STÖRUNGEN UND VERWENDUNG DAVON | [2018/40] | English: | DRUG FOR TREATING OR PREVENTING DISORDER CAUSED BY TGF- SIGNALS, AND APPLICATION THEREOF | [2018/40] | French: | MÉDICAMENT PERMETTANT LE TRAITEMENT OU LA PRÉVENTION D'UN TROUBLE PROVOQUÉ PAR DES SIGNAUX TGF-Â ET SON APPLICATION | [2018/40] | Entry into regional phase | 29.06.2018 | Translation filed | 29.06.2018 | National basic fee paid | 29.06.2018 | Search fee paid | 29.06.2018 | Designation fee(s) paid | 29.06.2018 | Examination fee paid | Examination procedure | 29.06.2018 | Examination requested [2018/40] | 29.06.2018 | Date on which the examining division has become responsible | 08.01.2020 | Amendment by applicant (claims and/or description) | 22.12.2020 | Despatch of a communication from the examining division (Time limit: M04) | 16.04.2021 | Reply to a communication from the examining division | 04.10.2022 | Despatch of a communication from the examining division (Time limit: M04) | 07.02.2023 | Reply to a communication from the examining division | Fees paid | Renewal fee | 12.12.2018 | Renewal fee patent year 03 | 13.12.2019 | Renewal fee patent year 04 | 14.12.2020 | Renewal fee patent year 05 | 16.12.2021 | Renewal fee patent year 06 | 21.12.2022 | Renewal fee patent year 07 | 15.11.2023 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y] - MAHESH SHIVANNA ET AL, "Barrier Dysfunction of the Corneal Endothelium in Response to TNF-[alpha]: Role of p38 MAP Kinase", INVESTIGATIVE OPTHALMOLOGY & VISUAL SCIENCE, US, (20100301), vol. 51, no. 3, doi:10.1167/iovs.09-4343, ISSN 1552-5783, pages 1575 - 1582, XP055343172 [Y] 1-15 * discussion;; figures 5-10 * DOI: http://dx.doi.org/10.1167/iovs.09-4343 | [XY] - JONG-SUK SONG ET AL, "Induction of FGF-2 Synthesis by IL-1? in Aqueous Humor through P13-Kinase and p38 in Rabbit Corneal Endothelium", INVESTIGATIVE OPTHALMOLOGY & VISUAL SCIENCE, US, (20100201), vol. 51, no. 2, doi:10.1167/iovs.09-4240, ISSN 1552-5783, pages 822 - 829, XP055387086 [X] 8,9 * § Transcorneal freezing procedure * [Y] 1-15 DOI: http://dx.doi.org/10.1167/iovs.09-4240 | International search | [XY]WO2015072580 (DOSHISHA [JP]) [X] 1-9, 12-17 * , claims 1 to 8; examples 1 to 17; paragraph [0050] & US 2016/0331736 A1 claims 1 to 18; examples 1 to 17; paragraph [0083] & EP 3069732 A1 & CA 2928626 A * [Y] 1-17; | [X]WO2013100208 (KYOTO PREFECTURAL PUBLIC UNIV CORP [JP], et al) [X] 10-11 * , claim 24; paragraph [0121]; example 13 & US 2015/0044178 A1 claim 24; example 13; paragraph [0208] & EP 2799537 A1 *; | [X]WO2015015655 (KYOTO PREFECTURAL PUBLIC UNIV CORP [JP], et al) [X] 10 * , example 1 (Family: none) *; | [Y]WO2015064768 (KYOTO PREFECTURAL PUBLIC UNIV CORP [JP], et al) [Y] 1-9, 12-17 * , & US 2016/0296505 A1 claims 1 to 14; examples 1 to 16 & EP 3064222 A1 & CA 2927898 A *; | [Y] - ADACHI, T. et al., "Contribution of p38 MAPK, NF-KB and glucocorticoid signaling pathways to ER stress-induced increase in retinal endothelial permeability", Archives of biochemistry and biophysics, (20120000), vol. 520, no. 1, pages 30 - 35, XP055393408 [Y] 1-17 * , ABSTRACT * DOI: http://dx.doi.org/10.1016/j.abb.2012.01.014 | [Y] - HUANG, Y. et al., "Endoplasmic reticulum stress- induced hepatic stellate cell apoptosis through calcium-mediated JNK/P38 MAPK and Calpain/ Caspase-12 pathways", Molecular and cellular biochemistry, (20140000), vol. 394, no. 1-2, pages 1 - 12, XP055496376 [Y] 1-17 * , Abstract, Fig. 8 * DOI: http://dx.doi.org/10.1007/s11010-014-2073-8 | [Y] - KIM, DO-SUNG et al., "p38 Mitogen-activated protein kinase is involved in endoplasmic reticulum stress-induced cell death and autophagy in human gingival fibroblasts", B iological & pharmaceutical bulletin, (20100000), vol. 33, no. 4, pages 545 - 549, XP055393409 [Y] 1-17 * , Abstract * DOI: http://dx.doi.org/10.1248/bpb.33.545 | [Y] - CORWIN, W.L. et al., "The unfolded protein response in human corneal endothelial cells following hypothermic storage: Implications of a novel stress pathway", Cryobiology, (20110000), vol. 63, no. 1, pages 46 - 55, XP055393410 [Y] 10-11 * , ABSTRACT * DOI: http://dx.doi.org/10.1016/j.cryobiol.2011.04.008 |